Clinical Trial Update: A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

An ongoing single-arm, open-label Phase 1/2 clinical trial evaluating VRT106 in combination with chemotherapy for resectable pancreatic cancer, currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• VRT106

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING